S&P 500

5.987,37

0,30%

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

Startseite
Investieren
Aktien
USA
USOTC
Endonovo Therapeutics Inc (PK) (ENDV)
Endonovo Therapeutics Inc (PK) (ENDV) News

ENDV

Endonovo Therapeutics (PK) (ENDV)

Endonovo Therapeutics Inc (PK)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:ENDV

1 2 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
19/09/2024	21h00	Edgar (US Regulatory)	Form SEC STAFF ACTION - SEC Staff Action: ORDER	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
02/02/2024	23h23	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
03/01/2024	23h30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
29/12/2023	21h20	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
04/12/2023	15h08	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
15/11/2023	18h21	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
12/10/2023	12h03	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
25/08/2023	13h04	Edgar (US Regulatory)	Form 1-A/A - Offering Statement [Regulation A]: [Amend]	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
21/08/2023	23h16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
14/06/2023	20h27	Edgar (US Regulatory)	Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
16/05/2023	12h02	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
17/04/2023	22h39	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
31/03/2023	21h55	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
29/03/2023	13h01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
14/11/2022	15h27	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
27/09/2022	19h31	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
22/08/2022	15h14	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
15/08/2022	15h46	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
16/05/2022	15h01	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
11/05/2022	00h36	Edgar (US Regulatory)	Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
31/03/2022	22h18	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
19/11/2021	15h02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
15/11/2021	16h12	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
23/08/2021	21h06	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
16/08/2021	16h11	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
24/05/2021	22h13	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
17/05/2021	22h45	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
13/04/2021	23h17	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
31/03/2021	23h01	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
19/11/2020	22h57	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)